共 50 条
- [31] Sacituzumab govitecan (IMMU-132) in patients with previously treated metastatic urothelial cancer (mUC): Results from a phase I/II study.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)Tagawa, Scott T.Faltas, Bishoy MorrisLam, Elaine TatSaylor, Philip JamesBardia, AdityaHajdenberg, JulioMorgans, Alicia K.Lim, Emerson A.Kalinsky, KevinSimpson, Pamela S.Galsky, Matt D.Goswam, TrishnaWegener, William A.Petrylak, Daniel Peter
- [32] Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter studyESMO OPEN, 2022, 7 (05)Simonelli, M.Garralda, E.Eskens, F.Gil-Martin, M.Yen, C-JObermannova, R.Chao, Y.Lonardi, S.Melichar, B.Moreno, VYu, M-LBongiovanni, A.Calvo, E.Rottey, S.Machiels, J-PGonzalez-Martin, A.Paz-Ares, L.Chang, C-LMason, W.Lin, C-CReardon, D. A.Vieito, M.Santoro, A.Meng, R.Abbadessa, G.Menas, F.Lee, H.Liu, Q.Combeau, C.Ternes, N.Ziti-Ljajic, S.Massard, C.
- [33] First-in-human study of the cancer peptide vaccine, TAS0313, in patients with advanced solid tumors: phase I dose finding part resultsJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7Yamamoto, NoboruSato, JunIwasa, SatoruYonemori, KanKoyama, TakafumiTamura, KenjiShimizu, ToshioKondo, SyunsukeKitano, Shigehisa
- [34] Intratumoral oncolytic virus V937 in combination with pembrolizumab (pembro) in patients (pts) with advanced melanoma: Updated results from the phase 1b CAPRA study.CANCER RESEARCH, 2021, 81 (13)Silk, Ann W.O'Day, Steven J.Kaufman, Howard L.Bryan, JenniferNorrell, Jacqueline T.Imbergamo, CaseyPortal, DaniellaZambrano-Acosta, EdwinPalmeri, MarisaFein, SeymourWu, CaiGuerreiro, LeslieMedina, DanielBommareddy, Praveen K.Zloza, AndrewFox, Bernard A.Ballesteros-Merino, CarmenShafren, DarrenGrose, MarkVieth, Joshua A.Mehnert, Janice M.
- [35] Preliminary results from a Phase Ib study of pixatimod (PG545) in combination with nivolumab in patients with advanced solid tumours with an expansion cohort in patients with metastatic pancreatic cancerEUROPEAN JOURNAL OF CANCER, 2018, 103 : E18 - E19Kuo, J.Bampton, D.Lemech, C. R.Brown, M. P.Stanley, A.Chojnowski, G.Hammond, E.Dredge, K.Goldstein, D.
- [36] Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I StudyCLINICAL GENITOURINARY CANCER, 2018, 16 (06) : 421 - +Parikh, MamtaPan, Chong-XianBeckett, Laurel A.Li, YuejuRobles, Daniel A.Aujla, Pawandeep K.Lara, Primo N., Jr.
- [37] First-in-human study of the cancer peptide vaccine, TAS0313, in patients with advanced solid tumors: Phase I dose-finding part resultsJOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)Yamamoto, NoboruSato, JunKondo, ShunsukeKoyama, TakafumiYonemori, KanIwasa, SatoruShimizu, Toshio
- [38] Updated results and biomarker analyses from the phase I trial of A166 in patients with HER2-expressing locally advanced or metastatic solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Hu, XichunZhang, JianLiu, RujiaoGao, ShuipingWu, JunyanWang, YingHao, YanrongGe, JunyouQing, YanYi, ShuliYang, QixianRao, HuajingYuan, Juanjuan
- [39] Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of HGS1029, an inhibitor of apoptosis protein (IAP) inhibitor, in patients (Pts) with advanced solid tumors: Results of a phase I study.JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Sikic, B. I.Eckhardt, S. G.Gallant, G.Burris, H. A.Camidge, D. R.Colevas, A. D.Jones, S. F.Messersmith, W. A.Wakelee, H. A.Li, H.Kaminker, P. G.Morris, S.Infante, J. R.
- [40] Intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours: Results from the expansion cohort of a phase I studyEUROPEAN JOURNAL OF CANCER, 2013, 49 (04) : 790 - 797Khayat, DavidTejpar, SabineSpano, Jean-PhilippeVerslype, ChrisBloch, JoelVandecaveye, VincentAssadourian, SylvieSoussan-Lazard, KarenCartot-Coton, SylvaineVan Cutsem, Eric